{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:28:52Z","timestamp":1793363332232,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jacc.2021.08.013","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T16:38:36Z","timestamp":1633451916000},"page":"1550-1563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"78","author":[{"given":"Alexander E.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cantrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Schuyler","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Rymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Washam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jacc.2021.08.013_bib1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.08.013_bib2","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2017.02.012","article-title":"Use of antiplatelet therapy\/DAPT for post-PCI patients undergoing noncardiac surgery","volume":"69","author":"Banerjee","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.08.013_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jcin.2017.10.051","article-title":"A\u00a0multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2","volume":"11","author":"Rossini","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2021.08.013_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4244\/EIJV9I2A35","article-title":"Outcomes of a preoperative \"bridging\" strategy with glycoprotein IIb\/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration","volume":"9","author":"Alshawabkeh","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2021.08.013_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.08.013_bib6","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1538-7836.2011.04456.x","article-title":"Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery","volume":"9","author":"Savonitto","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2021.08.013_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/bja\/aep373","article-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel","volume":"104","author":"Savonitto","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacc.2021.08.013_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jcin.2010.03.021","article-title":"Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry","volume":"3","author":"Berger","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2021.08.013_bib9","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.08.013_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCINTERVENTIONS.109.934703","article-title":"Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery","volume":"3","author":"Cruden","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2021.08.013_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jcin.2009.03.014","article-title":"Characterization of post-operative risk associated with prior drug-eluting stent use","volume":"2","author":"Anwaruddin","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2021.08.013_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.08.013_bib13","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.jacc.2016.09.967","article-title":"Risk associated with surgery within 12\u00a0months after coronary drug-eluting stent implantation","volume":"68","author":"Egholm","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.08.013_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/SLA.0000000000001246","article-title":"The incremental risk of coronary stents on postoperative adverse events: a matched cohort study","volume":"263","author":"Holcomb","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jacc.2021.08.013_bib15","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.08.013_bib16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.pcad.2017.12.004","article-title":"Evolution of coronary stent technology and implications for duration of dual antiplatelet therapy","volume":"60","author":"Moon","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2021.08.013_bib17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.08.013_bib18","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.jcin.2017.08.051","article-title":"Clinical outcomes following intravascular imaging-guided versus coronary angiography-guided percutaneous coronary intervention with stent implantation: a systematic review and Bayesian network meta-analysis of 31 studies and 17,882 patients","volume":"10","author":"Buccheri","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2021.08.013_bib19","first-page":"617","article-title":"Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery","volume":"89","author":"Armstrong","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2021.08.013_bib20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jcin.2012.07.012","article-title":"Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes","volume":"5","author":"Dangas","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2021.08.013_bib21","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1161\/CIRCULATIONAHA.113.003675","article-title":"Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery","volume":"128","author":"Capodanno","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.08.013_bib22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/hc2901.093504","article-title":"Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention","volume":"104","author":"Gilchrist","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.08.013_bib23","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/01.CIR.91.8.2151","article-title":"Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb\/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators","volume":"91","author":"Tcheng","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.08.013_bib24","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0002-9149(99)80345-2","article-title":"Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb\/IIIa inhibitor during percutaneous coronary intervention","volume":"76","author":"Harrington","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.08.013_bib25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0149-2918(04)90034-3","article-title":"Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function","volume":"26","author":"Gretler","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacc.2021.08.013_bib26","first-page":"575","article-title":"Bridging with glycoprotein IIb\/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents","volume":"79","author":"Ben Morrison","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2021.08.013_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.carrev.2018.11.018","article-title":"Intravenous antiplatelet therapy bridging in patients undergoing cardiac or non-cardiac surgery following percutaneous coronary intervention","volume":"20","author":"Dargham","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacc.2021.08.013_bib28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11239-016-1441-5","article-title":"Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients","volume":"43","author":"Waldron","year":"2017","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2021.08.013_bib29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2012.04.016","article-title":"Safety of \u201cbridging\u201d with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery","volume":"110","author":"Rassi","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.08.013_bib30","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.athoracsur.2011.07.052","article-title":"Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection","volume":"92","author":"Ceppa","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2021.08.013_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/HPC.0000000000000084","article-title":"Bridging experience with eptifibatide after stent implantation","volume":"15","author":"Barra","year":"2016","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.jacc.2021.08.013_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.mjt.0000071284.87458.a4","article-title":"Therapeutics of platelet glycoprotein IIb\/IIIa receptor antagonism","volume":"11","author":"Gowda","year":"2004","journal-title":"Am J Ther"},{"key":"10.1016\/j.jacc.2021.08.013_bib33","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable S, Symptoms Study I. Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.08.013_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12471-011-0197-y","article-title":"Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation","volume":"19","author":"Marcos","year":"2011","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jacc.2021.08.013_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2459\/JCM.0000000000000621","article-title":"Early myocardial surgical revascularization after ST-segment elevation myocardial infarction in multivessel coronary disease: bridge therapy is the solution?","volume":"19","author":"Polito","year":"2018","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jacc.2021.08.013_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3909\/ricm0498","article-title":"Bridging therapy in the perioperative management of patients with drug-eluting stents","volume":"10","author":"Chou","year":"2009","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacc.2021.08.013_bib37","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/phar.1956","article-title":"Bridging with tirofiban during oral antiplatelet interruption: a single-center case series analysis including patients on hemodialysis","volume":"37","author":"Walker","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2021.08.013_bib38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2459\/JCM.0b013e3282f37e58","article-title":"Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy","volume":"9","author":"D'Urbano","year":"2008","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jacc.2021.08.013_bib39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MCA.0b013e3283645c79","article-title":"Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction","volume":"24","author":"Xia","year":"2013","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacc.2021.08.013_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vph.2015.11.085","article-title":"Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: analysis of 314 patients","volume":"80","author":"De Servi","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jacc.2021.08.013_bib41","first-page":"25","article-title":"Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: a weighted meta-analysis of 280 patients from eight studies","volume":"85","author":"Warshauer","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2021.08.013_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0091270009344986","article-title":"Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist","volume":"50","author":"Akers","year":"2010","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacc.2021.08.013_bib43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.08.013_bib44","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.4244\/EIJ-D-18-00036","article-title":"Contemporary parenteral antiplatelet bridging strategies: a single-centre real-world experience at a tertiary\u00a0care centre","volume":"14","author":"Stern","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2021.08.013_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1060028018795840","article-title":"Antiplatelet therapy bridging with cangrelor in patients with coronary stents: a case series","volume":"53","author":"Bowman","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2021.08.013_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11239-018-1691-5","article-title":"Cangrelor use prior to left ventricular assist device surgery: a case series","volume":"46","author":"Washam","year":"2018","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2021.08.013_bib47","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jcin.2017.07.009","article-title":"Cangrelor use in cardiogenic shock: a single-center real-world experience","volume":"10","author":"Vaduganathan","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2021.08.013_bib48","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.jacc.2020.03.059","article-title":"Subcutaneous selatogrel inhibits platelet aggregation in patients with acute myocardial infarction","volume":"75","author":"Sinnaeve","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.08.013_bib49","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa1901778","article-title":"Antibody-based ticagrelor reversal agent in healthy volunteers","volume":"380","author":"Bhatt","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.08.013_bib50","first-page":"135","article-title":"Ticagrelor removal from human blood","volume":"2","author":"Angheloiu","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972105909X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972105909X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:45:48Z","timestamp":1760017548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972105909X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S073510972105909X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.08.013","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}